Mark A. Behlke
Director Técnico/Científico/I+D en Integrated DNA Technologies, Inc. .
Perfil
Mark A.
Behlke is the founder of Dicerna Pharmaceuticals, Inc. which was founded in 2007.
He is currently the Chief Scientific Officer at Integrated DNA Technologies, Inc. Dr. Behlke has a doctorate degree from Washington University in St. Louis which he received in 1988 and an undergraduate degree from Massachusetts Institute of Technology which he received in 1981.
Cargos activos de Mark A. Behlke
| Empresas | Cargo | Inicio |
|---|---|---|
Integrated DNA Technologies, Inc.
 Integrated DNA Technologies, Inc. Chemicals: SpecialtyProcess Industries Integrated DNA Technologies, Inc. manufactures nucleic acid products. It specializes in DNA synthesis, gene construction, antisense oligos, molecular beacons, and a variety of molecular biology products. The company was founded by Joseph A. Walder in 1987 and is headquartered in Skokie, IL. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Mark A. Behlke.
| Empresas | Cargo | Fin |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Fundador | - |
Formación de Mark A. Behlke.
| Massachusetts Institute of Technology | Undergraduate Degree |
| Washington University in St. Louis | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Integrated DNA Technologies, Inc.
Integrated DNA Technologies, Inc. Chemicals: SpecialtyProcess Industries Integrated DNA Technologies, Inc. manufactures nucleic acid products. It specializes in DNA synthesis, gene construction, antisense oligos, molecular beacons, and a variety of molecular biology products. The company was founded by Joseph A. Walder in 1987 and is headquartered in Skokie, IL. | Process Industries |
- Bolsa de valores
- Insiders
- Mark A. Behlke
